arrow
J

Johan Hartman

karolinska institutet
H指数:47
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma

Nur77激动剂增强针对肝细胞癌的自然杀伤细胞免疫

2026-06-300
OAAI
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助palbociclib联合内分泌治疗与化疗在ER+/HER2-乳腺癌中的比较:一项随机II期试验

2026-04-080
OAAI
Albacarcin V adds EPLIN as a novel and promising target for the treatment of female cancers and pediatric medulloblastoma

Albacarcin V将EPLIN添加为治疗女性癌症和儿科髓母细胞瘤的新颖且具有前景的靶点。

2025-12-060
PRE
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial

孕酮受体(PR)在绝经前乳腺癌中的肿瘤内异质性:一项随机试验的二次分析

2025-10-010
OAAI
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study

乳腺癌患者接受阿贝西利或瑞博西利辅助治疗的患病率与预后:一项全国性基于人群的研究

2025-09-290
OAAI
Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data

计算病理学注释增强了乳腺癌空间转录组学数据的分辨率和解释。

2025-09-090
OAAI
Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope (vol 15, 9343, 2024)

利用Tumoroscope对肿瘤异质性进行整合的空间与基因组分析(vol 15, 9343, 2024)

2025-03-210
OA
Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer
2024-12-270
PRE